Walgreens (WAG) August Comps Rose 3.7%

Walgreens (NYSE: WAG) had August sales of $6.39 billion, an increase of 3.6 percent from $6.16 billion for the same month in fiscal 2013.

Total front-end sales increased 2.1 percent in August compared with the same month in fiscal 2013, while comparable store front-end sales increased 1.4 percent. Customer traffic in comparable stores decreased 1.7 percent while basket size increased 3.1 percent.

Prescriptions filled at comparable stores increased by 1.1 percent in August and increased 3.2 percent on a calendar day-shift adjusted basis. August 2014 had one additional Sunday and one fewer Thursday compared with August 2013. These calendar shifts negatively impacted prescriptions filled at comparable stores by 2.1 percentage points.

August pharmacy sales increased by 5.4 percent. Comparable store pharmacy sales increased 5.0 percent and increased by a calendar day-shift adjusted 7.1 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 2.1 percentage points. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 1.8 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 65.7 percent of total sales for the month.

Sales in comparable stores increased by 3.7 percent in August. Calendar day shifts negatively impacted total comparable sales by 1.4 percentage points. Generic drug introductions in the last 12 months negatively impacted total comparable sales by 1.2 percentage points.

Total sales for the fourth quarter of fiscal 2014, which ended Aug. 31, were 19.06 billion, up 6.2 percent from 17.95 billion in last year’s quarter. Comparable store sales for the fourth quarter of fiscal 2014 increased 5.6 percent, while front-end comparable store sales for the quarter increased 1.3 percent. Prescriptions filled at comparable stores increased 3.9 percent in the fourth quarter and comparable pharmacy sales increased 8.2 percent.

Calendar 2014 year-to-date sales for the first eight months were $50.91 billion, an increase of 5.7 percent from $48.19 billion in 2013.

Total sales for fiscal 2014 were $76.43 billion, an increase of 5.8 percent from $72.23 billion in fiscal 2013.

You May Also Be Interested In

• Western Union chief legal officer to retire in November 2026
• BTIG Downgrades TripAdvisor (TRIP) to Neutral, 'Wrong Side of AI'
• Neurocrine Biosciences names three senior vice presidents